Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study

See Dujardin (doi:10.1093/brain/awu218) for a scientific commentary on this article. Nombela et al. present data from the ICICLE-PD study of cognition in newly diagnosed Parkinson’s disease. Consistent with the ‘Dual Syndrome’ hypothesis, impairments in executive function reflect a frontal dopaminergic syndrome modulated by COMT genotype, while visuospatial and memory deficits reflect disruption of temporo-parietal systems modulated by MAPT and APOE.

[1]  John L. Robinson,et al.  Neuropathologic substrates of Parkinson disease dementia , 2012, Annals of neurology.

[2]  A. Owen,et al.  Hypoconnectivity and Hyperfrontality in Retired American Football Players , 2013, Scientific Reports.

[3]  T. Robbins,et al.  A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. , 1988, Brain : a journal of neurology.

[4]  Oury Monchi,et al.  Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease , 2014, Neurobiology of Aging.

[5]  M. Ban,et al.  Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. , 2007, Annals of neurology.

[6]  B. Schmand,et al.  Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.

[7]  M. D’Esposito,et al.  Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control , 2011, Biological Psychiatry.

[8]  P. Moberg,et al.  Neurodegeneration across stages of cognitive decline in Parkinson disease. , 2011, Archives of neurology.

[9]  M. Ban,et al.  Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. , 2013, Brain : a journal of neurology.

[10]  T. Robbins,et al.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. , 2004, Brain : a journal of neurology.

[11]  S. Tsuji,et al.  Apolipoprotein E ε4 allele and progression of cortical Lewy body pathology in Parkinson’s disease , 1998, Acta Neuropathologica.

[12]  J. Poirier,et al.  The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain , 2012, Experimental Neurology.

[13]  T. Robbins,et al.  Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease , 2007, The Journal of Neuroscience.

[14]  P. Goldman-Rakic,et al.  Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  Keith A. Johnson,et al.  Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia , 2013, Neurology.

[16]  K. Hugdahl,et al.  Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia , 2006, Movement disorders : official journal of the Movement Disorder Society.

[17]  J. Haines,et al.  Apolipoprotein E controls the risk and age at onset of Parkinson disease , 2004, Neurology.

[18]  J. Jolles,et al.  Functional integration of parietal lobe activity in early Alzheimer disease , 2012, Neurology.

[19]  Xuemei Huang,et al.  Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. , 2006, Archives of neurology.

[20]  D. Aarsland,et al.  The Epidemiology of Dementia Associated with Parkinson's Disease , 2010, Brain pathology.

[21]  T. Robbins,et al.  Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. , 2002, Brain : a journal of neurology.

[22]  T. Robbins,et al.  The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study. , 2012, Brain : a journal of neurology.

[23]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[24]  D. Aarsland,et al.  The epidemiology of dementia associated with Parkinson disease , 2010, Journal of the Neurological Sciences.

[25]  A. Siderowf,et al.  Genetic influences on cognitive decline in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[26]  Mark S. Cohen,et al.  Changes in cortical activity during mental rotation. A mapping study using functional MRI. , 1996, Brain : a journal of neurology.

[27]  Susan Bookheimer,et al.  APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. , 2009, Annual review of clinical psychology.

[28]  T. Shallice.  Specific impairments of planning. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  Adrian M. Owen,et al.  Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man , 1995, Neuropsychologia.

[30]  Keith A. Johnson,et al.  Brain amyloid and cognition in Lewy body diseases , 2012, Movement disorders : official journal of the Movement Disorder Society.

[31]  I. M. Harris,et al.  Selective right parietal lobe activation during mental rotation: a parametric PET study. , 2000, Brain : a journal of neurology.

[32]  W. C. Culbertson,et al.  Evidence for Impaired Encoding and Retrieval Memory Profiles in Parkinson Disease , 2004, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[33]  A. Owen.  Working memory in dorsolateral frontal cortex , 1998, Trends in Cognitive Sciences.

[34]  P. Thompson,et al.  Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  H. Nelson,et al.  Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test , 1978, Cortex.

[36]  Adam Hampshire,et al.  Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. , 2008, Brain : a journal of neurology.

[37]  Juliet M. Taylor,et al.  Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease , 2013, Neurochemistry International.

[38]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[39]  A. Goris,et al.  Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease , 2009, Journal of Neurology.

[40]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[41]  K. Fuxe,et al.  Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat , 1981, Neuroscience Letters.

[42]  L. Forsgren,et al.  Cognitive function in early Parkinson’s disease: a population‐based study , 2009, European journal of neurology.

[43]  T. Goldberg,et al.  Genes and the parsing of cognitive processes , 2004, Trends in Cognitive Sciences.

[44]  S. Tiamkao,et al.  Association between apolipoprotein E genotypes and Parkinson’s disease , 2011, Journal of Clinical Neuroscience.

[45]  E. Tolosa,et al.  Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease , 2013, Hippocampus.

[46]  A. Grunewald.  Stimulating thoughts about heading perception , 1998, Trends in Cognitive Sciences.

[47]  Adrian M. Owen,et al.  Fractionating Human Intelligence , 2012, Neuron.

[48]  E. Tolosa,et al.  Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease , 2008, Neuroscience Letters.

[49]  R. Camicioli,et al.  Source memory in normal aging and Parkinson's disease. , 2013, Journal of neuropsychology.

[50]  O. Tysnes,et al.  Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. , 2013, JAMA neurology.

[51]  Jeffrey M. Zacks,et al.  Neuroimaging Studies of Mental Rotation: A Meta-analysis and Review , 2008, Journal of Cognitive Neuroscience.

[52]  A. Cronin-Golomb,et al.  Visuospatial dysfunction and problem solving in Parkinson's disease. , 1997, Neuropsychology.

[53]  P. Grasby,et al.  The Effects of The COMT val108/158met Polymorphism on BOLD Activation During Working Memory, Planning, and Response Inhibition: A Role for The Posterior Cingulate Cortex? , 2011, Neuropsychopharmacology.

[54]  I. Deary,et al.  COMT genotype and cognitive ability: A longitudinal aging study , 2007, Neuroscience Letters.

[55]  David N. Rider,et al.  Genomic determinants of motor and cognitive outcomes in Parkinson's disease. , 2012, Parkinsonism & related disorders.

[56]  H. Goodglass,et al.  Some linguistic structures in the speech of a Broca's aphasic. , 1972, Cortex; a journal devoted to the study of the nervous system and behavior.

[57]  Matthew Brett,et al.  Dissociable contributions of the mid-ventrolateral frontal cortex and the medial temporal lobe system to human memory , 2006, NeuroImage.

[58]  M. Onofrj,et al.  Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks. , 2010, Parkinsonism & related disorders.

[59]  Karl J. Friston,et al.  Scanning patients with tasks they can perform , 1999, Human brain mapping.

[60]  K. Heilman,et al.  Mental object rotation in Parkinson's disease , 2003, Journal of the International Neuropsychological Society.

[61]  Ivan Toni,et al.  The prefrontal cortex: response selection or maintenance within working memory? , 2000, 5th IEEE EMBS International Summer School on Biomedical Imaging, 2002..

[62]  Arthur L. Benton,et al.  Differential behavioral effects in frontal lobe disease , 1968 .

[63]  Angie A. Kehagia,et al.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.

[64]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[65]  Lars-Göran Nilsson,et al.  Catechol O-Methyltransferase Val158Met Polymorphism is Associated with Cognitive Performance in Nondemented Adults , 2005, Journal of Cognitive Neuroscience.

[66]  C. Marsden,et al.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease. , 1992, Brain : a journal of neurology.

[67]  R. Dolan,et al.  Neural systems engaged by planning: a PET study of the Tower of London task , 1996, Neuropsychologia.

[68]  D. Aarsland,et al.  Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. , 2011, Neuropsychology.

[69]  R. Poldrack.  Region of interest analysis for fMRI. , 2007, Social cognitive and affective neuroscience.

[70]  T. Robbins,et al.  Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry , 2003, The Journal of Neuroscience.

[71]  Roger A. Barker,et al.  Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis , 2012, Neurodegenerative Diseases.

[72]  J. Nutt,et al.  The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile , 2008, Movement disorders : official journal of the Movement Disorder Society.

[73]  M. Egan,et al.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.

[74]  B. Schmand,et al.  Catechol‐O‐methyltransferase val158met and cognitive function in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[75]  A. Lee,et al.  Impairments of mental rotation in Parkinson's disease , 1998, Neuropsychologia.

[76]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[77]  L. Nyberg,et al.  Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study , 2012, The Lancet Neurology.

[78]  M. Petrides,et al.  Functional organization of spatial and nonspatial working memory processing within the human lateral frontal cortex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Nalls,et al.  A large study reveals no association between APOE and Parkinson's disease , 2012, Neurobiology of Disease.

[80]  M. Barcikowska,et al.  TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors , 2013, Neurobiology of Aging.

[81]  D. Eckstein,et al.  Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition , 2008, Brain : a journal of neurology.

[82]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[83]  John Duncan,et al.  Frontal lobe involvement in spatial span: Converging studies of normal and impaired function , 2006, Neuropsychologia.

[84]  T. Robbins,et al.  Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism , 2004, Movement disorders : official journal of the Movement Disorder Society.

[85]  T. Robbins,et al.  Characterizing mild cognitive impairment in incident Parkinson disease , 2014, Neurology.

[86]  A M Owen,et al.  Prefrontal dopamine levels determine the balance between cognitive stability and flexibility. , 2013, Cerebral cortex.

[87]  A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson’s disease , 2014, Acta Neurologica Belgica.

[88]  Alan C. Evans,et al.  Planning and Spatial Working Memory: a Positron Emission Tomography Study in Humans , 1996, The European journal of neuroscience.

[89]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[90]  Thomas Foltynie,et al.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.

[91]  S. Tsuji,et al.  Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. , 1998, Acta neuropathologica.

[92]  K. Marder,et al.  Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study , 2010, Journal of the International Neuropsychological Society.

[93]  Michael C. Corballis,et al.  Mental Rotation and the Right Hemisphere , 1997, Brain and Language.

[94]  T. Robbins,et al.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[95]  T. Robbins,et al.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.

[96]  J. Kulisevsky,et al.  Cognitive impairment in nondemented Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[97]  W. Gowers,et al.  A Manual of Diseases of the Nervous System , 1887, Edinburgh Medical Journal.

[98]  R. Barker,et al.  The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease , 2010, Neurobiology of Aging.

[99]  R. E. Passingham,et al.  Imaging the mental components of a planning task , 2001, Neuropsychologia.

[100]  G. Ganis,et al.  Frontostriatal circuits are necessary for visuomotor transformation: Mental rotation in Parkinson's disease , 2006, Neuropsychologia.